SCYNEXIS, Inc. 0L49.L Stock
SCYNEXIS, Inc. Price Chart
SCYNEXIS, Inc. 0L49.L Financial and Trading Overview
| SCYNEXIS, Inc. stock price | 1.97 USD |
| Previous Close | 2.99 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 3.77 USD |
| Volume | 1.9K USD |
| Avg. Volume | 6K USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 2.128873 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.204 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0L49.L Valuation Measures
| Enterprise Value | 95.63M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 17.28 |
| Enterprise Value/EBITDA | -1.257 |
Trading Information
SCYNEXIS, Inc. Stock Price History
| Beta (5Y Monthly) | 2.128873 |
| 52-Week Change | 44.01% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.77 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 2.76 USD |
| 200-Day Moving Average | 2.4 USD |
0L49.L Share Statistics
| Avg. Volume (3 month) | 6K USD |
| Avg. Daily Volume (10-Days) | 1.05K USD |
| Shares Outstanding | N/A |
| Float | 33.36M |
| Short Ratio | N/A |
| % Held by Insiders | 1.87% |
| % Held by Institutions | 52.98% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 0.1:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1385.99% |
| Gross Margin | 87.96% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -52.71% |
| Return on Equity (ttm) | -2024.49% |
Income Statement
| Revenue (ttm) | 5.53M USD |
| Revenue Per Share (ttm) | 0.12 USD |
| Quarterly Revenue Growth (yoy) | 64.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -76099000 USD |
| Net Income Avi to Common (ttm) | -91234000 USD |
| Diluted EPS (ttm) | -1.204 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 54.82M USD |
| Total Cash Per Share (mrq) | 1.5 USD |
| Total Debt (mrq) | 48.75M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.309 |
| Book Value Per Share (mrq) | -0.898 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -82818000 USD |
| Levered Free Cash Flow (ttm) | -47228124 USD |
Profile of SCYNEXIS, Inc.
| Country | United Kingdom |
| State | NJ |
| City | Jersey City |
| Address | 1 Evertrust Plaza |
| ZIP | 07302-6548 |
| Phone | 201 884 5485 |
| Website | https://www.scynexis.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 36 |
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment of fungal infections in the United States. It offers BREXAFEMME for the treatment of vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, an intravenous drug for the treatment of various fungal infections, including invasive candidiasis, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Q&A For SCYNEXIS, Inc. Stock
What is a current 0L49.L stock price?
SCYNEXIS, Inc. 0L49.L stock price today per share is 1.97 USD.
How to purchase SCYNEXIS, Inc. stock?
You can buy 0L49.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SCYNEXIS, Inc.?
The stock symbol or ticker of SCYNEXIS, Inc. is 0L49.L.
How many shares does SCYNEXIS, Inc. have in circulation?
The max supply of SCYNEXIS, Inc. shares is 0.
What is SCYNEXIS, Inc. Price to Earnings Ratio (PE Ratio)?
SCYNEXIS, Inc. PE Ratio is now.
What was SCYNEXIS, Inc. earnings per share over the trailing 12 months (TTM)?
SCYNEXIS, Inc. EPS is -1.204 USD over the trailing 12 months.